From Wikipedia, the free encyclopedia
Propatylnitrate
|
Names
|
IUPAC name
2,2-bis(nitrooxymethyl)butyl nitrate
|
Identifiers
|
|
|
3D model (JSmol)
|
|
ChEMBL
|
|
ChemSpider
|
|
ECHA InfoCard
|
100.018.970
|
|
|
UNII
|
|
|
|
InChI=1S/C6H11N3O9/c1-2-6(3-16-7(10)11,4-17-8(12)13)5-18-9(14)15/h2-5H2,1H3 YKey: YZZCJYJBCUJISI-UHFFFAOYSA-N Y
|
CCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]
|
Properties
|
|
C6H11N3O9
|
Molar mass
|
269.17 g/mol
|
Pharmacology
|
|
C01DA07 (WHO)
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
N (what is Y N ?)
|
Infobox references
|
|
|
Chemical compound
Propatylnitrate (propatyl nitrate) is a nitrate.[1]
References[]
|
---|
Forms | |
---|
Targets | |
---|
NO donors (prodrugs) | |
---|
Enzyme (inhibitors) | |
---|
Others |
- Indirect/downstream NO modulators: ACE inhibitors/AT-II receptor antagonists (e.g., captopril, losartan)
- ETB receptor antagonists (e.g., bosentan)
- L-Type calcium channel blockers (e.g., dihydropyridines: nifedipine)
- Nebivolol (beta blocker)
- PDE5 inhibitors (e.g., sildenafil)
- non-selective PDE inhibitors (e.g., caffeine)
- PDE9 inhibitors (e.g., paraxanthine)
- cGMP preferring PDE inhibitors (e.g., sildenafil, paraxanthine, tadalafil)
- Statins (e.g., simvastatin)
|
---|
See also: Receptor/signaling modulators |
Categories:
- Nitrate esters
- Cardiovascular system drug stubs
Hidden categories:
- Articles without InChI source
- Articles without KEGG source
- Chembox CAS registry number linked
- Articles with changed CASNo identifier
- ECHA InfoCard ID from Wikidata
- Pages using collapsible list with both background and text-align in titlestyle
- Articles containing unverified chemical infoboxes
- Articles with short description
- Short description matches Wikidata
- All stub articles